The effects of octreotide in a patient with Nelson's syndrome.
We have administered octreotide, 100 micrograms tid, to a 27-year-old man with Nelson's syndrome. After seven days of therapy, adrenocorticotropin levels fell to 54% of initial values, and some shrinkage of the tumour was observed. This study indicates that octreotide therapy may have a role in the treatment of Nelson's syndrome.
Kelestimur
F
F
Department of Internal Medicine, Erciyes University Medical School, 38039 Kayseri-Turkey.
Utas
C
C
Ozbakir
O
O
Selçuklu
A
A
Kandemir
O
O
Ozcan
N
N
D000324:Adrenocorticotropic Hormone / Q000097:blood; D000328:Adult; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D009347:Nelson Syndrome / Q000097:blood / Q000188:drug therapy*; D015282:Octreotide / Q000627:therapeutic use*
D018931:Antineoplastic Agents, Hormonal; D000324:Adrenocorticotropic Hormone; D015282:Octreotide